AlvioLife® (Respiratory Health & Performance)

Boswellia serrata + Aegle marmelos
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

AlvioLife® (PLT Health Solutions) is a patented botanical blend combining Spilanthes acmella (toothache plant) and Boswellia serrata extracts to support respiratory health, easier breathing, and enhanced physical performance. By targeting bronchial airway inflammation and improving respiratory efficiency, AlvioLife® addresses a foundational aspect of endurance performance — oxygen delivery — through a non-stimulant botanical mechanism.

Studied Dose Per AlvioLife® clinical dosing; PLT Health Solutions product specifications
Active Compound Boswellia serrata resin extract (standardized to 30% AKBA — 3-O-acetyl-11-keto-β-boswellic acid) + Aegle marmelos (Bengal quince) fruit extract — AlvioLife® / LI13109F by PLT Health Solutions / Laila Nutraceuticals; standardized for 5-LOX inhibition activity. Synergistic respiratory and immune modulation blend.

Benefits

Easier breathing and airway support

AlvioLife® reduces bronchial airway inflammation through Boswellia's AKBA (acetyl-11-keto-β-boswellic acid) inhibition of 5-lipoxygenase — the enzyme producing leukotrienes that trigger bronchoconstriction and airway inflammation. This mechanism is the same target as pharmaceutical leukotriene inhibitors (montelukast) but through a botanical route, supporting freer, less restricted breathing.

Enhanced physical performance and VO2

By improving respiratory efficiency and reducing airway resistance, AlvioLife® allows athletes to draw more oxygen per breath — translating to improved VO2 utilization, greater endurance capacity, and better performance during sustained aerobic exercise. Clinical studies show improvements in respiratory function markers and exercise performance.

Immune and respiratory resilience

Spilanthes acmella provides immunostimulatory alkylamides (spilanthol) that activate macrophages and natural killer cells — enhancing upper respiratory immune defense. The combination of anti-inflammatory Boswellia and immunostimulatory Spilanthes creates a dual protective and active immune profile for respiratory health.

Mechanism of action

1

5-LOX inhibition and leukotriene reduction

AKBA from Boswellia serrata selectively inhibits 5-lipoxygenase (5-LOX) — the enzyme responsible for converting arachidonic acid to pro-inflammatory leukotrienes (LTB4, LTC4, LTD4). Leukotrienes are the primary mediators of bronchospasm, mucus hypersecretion, and airway inflammation in respiratory conditions. By blocking 5-LOX, AlvioLife® reduces leukotriene-driven airway constriction and inflammation without the COX inhibition side effects of NSAIDs.

Clinical trials

1
AlvioLife® (B. serrata + A. marmelos) Asthma RCT — Pungle 2017
PubMed

Manufacturer-published (PLT Health Solutions) clinical study examining AlvioLife® (a proprietary blend of Boswellia serrata and Aegle marmelos extracts) on respiratory function, breathing comfort, and exercise performance markers. Note: full details available via PLT Health Solutions; not currently indexed in PubMed.

Mild-to-moderate asthma patients. Randomized, double-blind, placebo-controlled clinical study of LI13109F (AlvioLife®, the patented Boswellia serrata + Aegle marmelos blend) on asthma symptoms and lung function.

AlvioLife® significantly alleviated symptoms of asthma vs placebo, with improvements in lung function and reductions in symptom severity. Published in PMID 29210124. A subsequent 6-week RCT in 2021 (PLT-funded, n=200mg/day in air-pollution-sensitive subjects) reported up to 16% improved FEV1, 30% improved FVC, 7% improved 6-min walk capacity, ~40% reduction in upper respiratory tract symptoms (WURSS-21), and 18% improvement in psychological well-being (PGWBI) — that pollution-sensitivity trial is in pre-publication and findings here come from PLT press releases.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated
Boswellia component — rare GI effects; take with food
Spilanthes component — mild tingling sensation (spilanthol) is normal

Important Drug interactions

Anticoagulants — Boswellia has mild antiplatelet activity; monitor if on blood thinners
Asthma medications — complementary anti-inflammatory mechanism; not a replacement for prescribed asthma therapy

Frequently asked questions about AlvioLife® (Respiratory Health & Performance)

What is AlvioLife® (Respiratory Health & Performance)?

AlvioLife® (PLT Health Solutions) is a patented botanical blend combining Spilanthes acmella (toothache plant) and Boswellia serrata extracts to support respiratory health, easier breathing, and enhanced physical performance.

What does AlvioLife® (Respiratory Health & Performance) do?

AKBA from Boswellia serrata selectively inhibits 5-lipoxygenase (5-LOX) — the enzyme responsible for converting arachidonic acid to pro-inflammatory leukotrienes (LTB4, LTC4, LTD4). In clinical research, AlvioLife® (Respiratory Health & Performance) has been studied for easier breathing and airway support, enhanced physical performance and vo2, immune and respiratory resilience.

Who should take AlvioLife® (Respiratory Health & Performance)?

AlvioLife® (Respiratory Health & Performance) may be most relevant for people interested in athletic performance, immune support, respiratory health. It has been clinically studied for easier breathing and airway support, enhanced physical performance and vo2, immune and respiratory resilience. As with any supplement, consult your healthcare provider before starting, especially if you have medical conditions or take prescription medications.

How long does AlvioLife® (Respiratory Health & Performance) take to work?

Most clinical trial effects appear over weeks of consistent use; individual response varies. Acute or same-day effects (where applicable) typically appear within hours, but most cumulative benefits — particularly those affecting biomarkers, mood, sleep quality, or chronic symptoms — require 4-12 weeks of regular use to fully assess. If you don't notice benefit after 12 weeks at the appropriate dose, it may not be your responder.

When is the best time to take AlvioLife® (Respiratory Health & Performance)?

For performance or energy goals, AlvioLife® (Respiratory Health & Performance) is typically taken 30-60 minutes before exercise or in the morning. Some people take it with food to reduce GI sensitivity; others prefer empty-stomach timing for faster absorption. Always check product labeling and follow personalized guidance from your healthcare provider.

Is AlvioLife® (Respiratory Health & Performance) worth taking?

AlvioLife® (Respiratory Health & Performance) has moderate clinical evidence (Evidence Level 3/5 on NutraSmarts) — meaningful trial support exists, though results are less consistent than top-tier ingredients. Whether it's worth taking depends on your specific goals, what you've already tried, your budget, and your overall supplement strategy. The honest framing: no supplement is essential for most people, and lifestyle factors (sleep, exercise, diet, stress management) typically produce larger effects than any single supplement. AlvioLife® (Respiratory Health & Performance) is most worth trying if its evidence-supported uses align with your specific goals.

What is the recommended dosage of AlvioLife® (Respiratory Health & Performance)?

The clinically studied dose for AlvioLife® (Respiratory Health & Performance) is Per AlvioLife® clinical dosing; PLT Health Solutions product specifications. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is AlvioLife® (Respiratory Health & Performance) used for?

AlvioLife® (Respiratory Health & Performance) is studied for easier breathing and airway support, enhanced physical performance and vo2, immune and respiratory resilience. AlvioLife® reduces bronchial airway inflammation through Boswellia's AKBA (acetyl-11-keto-β-boswellic acid) inhibition of 5-lipoxygenase — the enzyme producing leukotrienes that trigger bronchoconstriction and airway inflammation.